Childhood Cancer

You are here

Home » Grants » All grants tagged with "Brain Tumors"

All grants tagged with "Brain Tumors"

Development of a pooled cell fitness assay to evaluate pediatric cancer dependencies
Mark Zhai
St. Jude Children’s Research Hospital
POST Program Grants, Awarded 2023
Targeting the mTORC1/4E-BP1 axis in Group 4 medulloblastoma
Madison Dick
Hospital for Sick Children
POST Program Grants, Awarded 2023
FGFR1 alterations in pediatric gliomas
Angela Deleon
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2023
Neuronal Regulation of Pediatric Brain Tumor Growth
Lara Isabel Marco Y Marquez
Washington University
POST Program Grants, Awarded 2023
Investigating the cooperative roles of RNA binding protein LIN28B and MYC in group 3 medulloblastoma.
Shane Grele
The Regents of the University of California San Francisco
POST Program Grants, Awarded 2023
Exploring the role of TP53 mutations in the radioresistance of Diffuse Intrinsic Pontine Glioma (DIPG)
Angelica Rivera-Martinez
University of Kentucky Research Foundation
POST Program Grants, Awarded 2023
Uncovering the molecular targets of a novel MYC inhibitor for medulloblastoma
Anastasia Blamey
Columbia University
POST Program Grants, Awarded 2023
Phase I trial of multilamellar mRNA lipid particles for recurrent pediatric high grade glioma
Elias Sayour, MD/PhD
University of Florida
R Accelerated Award Grants, Awarded 2022
Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system
Sriram Venneti, MD/PhD
The Regents of the University of Michigan
R Accelerated Award Grants, Awarded 2022
Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG
Meredith Morgan, PhD & Daniel Wahl, MD/PhD
The Regents of the University of Michigan
Reach Grants, Awarded 2022

Pages

All childhood cancer types

Featured Hero

Sam Glossi

At 3-and-a-half years old, Sam's parents found a large lump on Sam's abdomen. He underwent surgery to remove it and was cancer-free for a short time. When the cancer returned, it was treated like stage 4 neuroblastoma. Sam has been cancer-free since 2017!
Read more »